Raffles Medical Group Ltd

As of June 30, 2020, Raffles Medical Group Ltd. carries a market capitalization of 1.18B, placing it among publicly traded companies globally. Its enterprise value stands at 1.22B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Raffles Medical Group Ltd.'s next confirmed earnings release is scheduled for February 22, 2027.

As of June 30, 2020, Raffles Medical Group Ltd. has 1.83B shares outstanding.

These figures are as of June 30, 2020.

As of June 30, 2020, Raffles Medical Group Ltd. maintains a current ratio of 1.10, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2020, Raffles Medical Group Ltd. recorded 8.69M in income tax expense.

As of the close on September 21, 2026, Raffles Medical Group Ltd.'s stock has declined approximately 20.25% over the past 52 weeks. The 50-day moving average sits at 0.85, while the 200-day moving average is 0.83.

As of June 30, 2020, Raffles Medical Group Ltd. holds 109.53M in cash and equivalents against 145.11M in total debt, resulting in a net debt position of 11.33M. Total book value stands at 619.95M, with working capital of 17.30M providing operational flexibility.

These figures cover the twelve months ended June 30, 2020.

Over the twelve months ended June 30, 2020, Raffles Medical Group Ltd. paid dividends of 0.01 per share.

Raffles Medical Group Ltd.'s most recent stock split took place on May 11, 2016 with a 1:3 split ratio.